EP Patent

EP3069785A1 — Limit size lipid nanoparticles and related methods

Assigned to University of British Columbia · Expires 2016-09-21 · 10y expired

What this patent protects

Limit size lipid nanoparticles, methods for using the lipid nanoparticles, and methods and systems for making limit size lipid nanoparticles.

USPTO Abstract

Limit size lipid nanoparticles, methods for using the lipid nanoparticles, and methods and systems for making limit size lipid nanoparticles.

Drugs covered by this patent

Patent Metadata

Patent number
EP3069785A1
Jurisdiction
EP
Classification
—
Expires
2016-09-21
Drug substance claim
No
Drug product claim
No
Assignee
University of British Columbia
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.